Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health
CCR - For Our Staff| Home |

Our Science – Van Dyke Website

Terry A. Van Dyke, Ph.D.

Selected Publications

1)  Szabova L, Bupp S, Kamal M, Householder DB, Hernandez L, Schlomer JJ, Baran ML, Yi M, Stephens RM, Annunziata CM, Martin PL, Van Dyke TA, Ohler ZW, Difilippantonio S.
Pathway-specific engineered mouse allograft models functionally recapitulate human serous epithelial ovarian cancer.
PLoS ONE. 9: e95649, 2014.
2)  Song Y, Gilbert D, O'Sullivan TN, Yang C, Pan W, Fathalizadeh A, Lu L, Haines DC, Martin PL, Van Dyke T.
Carcinoma initiation via RB tumor suppressor inactivation: a versatile approach to epithelial subtype-dependent cancer initiation in diverse tissues.
PLoS ONE. 8: e80459, 2013.
3)  Vitucci M, Karpinich NO, Bash RE, Werneke AM, Schmid RS, White KK, McNeill RS, Huff B, Wang S, Van Dyke T, Miller CR.
Cooperativity between MAPK and PI3K signaling activation is required for glioblastoma pathogenesis.
Neuro-oncology. 15: 1317-29, 2013.
4)  Walter AO, Sjin RT, Haringsma HJ, Ohashi K, Sun J, Lee K, Dubrovskiy A, Labenski M, Zhu Z, Wang Z, Sheets M, St Martin T, Karp R, van Kalken D, Chaturvedi P, Niu D, Nacht M, Petter RC, Westlin W, Lin K, Jaw-Tsai S, Raponi M, Van Dyke T, Etter J, Weaver Z, Pao W, Singh J, Simmons AD, Harding TC, Allen A.
Discovery of a mutant-selective covalent inhibitor of EGFR that overcomes T790M-mediated resistance in NSCLC.
Cancer Discov. 3: 1404-15, 2013.
5)  Song Y, Zhang Q, Kutlu B, Difilippantonio S, Bash R, Gilbert D, Yin C, O'Sullivan TN, Yang C, Kozlov S, Bullitt E, McCarthy KD, Kafri T, Louis DN, Miller CR, Hood L, Van Dyke T.
Evolutionary etiology of high-grade astrocytomas.
Proc. Natl. Acad. Sci. U.S.A. 110: 17933-8, 2013.
6)  Merlino G, Flaherty K, Acquavella N, Day C, Aplin A, Holmen S, Topalian S, Van Dyke T, Herlyn M.
Meeting report: The future of preclinical mouse models in melanoma treatment is now.
Pigment Cell Melanoma Res. 26: E8-E14, 2013.
7)  Pérez de Castro I, Aguirre-Portolés C, Fernández-Miranda G, Cañamero M, Cowley DO, Van Dyke T, Malumbres M.
Requirements for Aurora-A in tissue regeneration and tumor development in adult mammals.
Cancer Res. 73: 6804-15, 2013.
8)  Van Dyke T, Merlino G.
Beta-catenin in metastatic melanoma--the smoking gun reloaded.
Pigment Cell Melanoma Res. 25: 125-6, 2012.
9)  Yoon Y, Cowley D, Gallant J, Jones S, Van Dyke T, Rivera-Perez J.
Conditional Aurora A deficiency differentially affects early mouse embryo patterning.
Dev Biol. 371: 77-85, 2012.
10)  Szabova L, Yin C, Bupp S, Guerin TM, Schlomer JJ, Householder DB, Baran ML, Yi M, Song Y, Sun W, McDunn JE, Martin PL, Van Dyke T, Difilippantonio S.
Perturbation of Rb, p53 and Brca1 or Brca2 cooperate in inducing metastatic serous epithelial ovarian cancer.
Cancer Res. 72: 4141-53, 2012.
Click Here to View Expanded Bibliography.

This page was last updated on 5/19/2014.